These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2573370

  • 1. Antihypertensive action of beta-adrenoceptor blocking drugs. The role of intrarenal mechanisms.
    Struyker-Boudier HA, Smits JF.
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):237S-240S. PubMed ID: 2573370
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Renal hemodynamic effects of tertatolol in essential hypertension.
    Paillard F, Lantz B, Leviel F, Ardaillou R.
    Am J Nephrol; 1986 Nov; 6 Suppl 2():40-4. PubMed ID: 2879472
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment.
    Fallo F, Gregianin M, Bui F, Macrì C, Folino P, Mantero F.
    Eur J Clin Pharmacol; 1991 Nov; 40(3):309-11. PubMed ID: 1676368
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A, Leonetti G, Bernini GP, Rupoli L, Lucarini AR, Sangiorgio P, Mauro M, Di Stratis P, Zanchetti A.
    Am J Nephrol; 1986 Nov; 6 Suppl 2():45-9. PubMed ID: 2879473
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beta blockers induce different intrarenal effects in humans: demonstration by selective infusion of tertatolol and propranolol.
    Nitenberg A, Chemla D, Blanchet F, Guery O, Prost JF, Dutray-Dupagne C.
    J Clin Pharmacol; 1990 Oct; 30(10):930-7. PubMed ID: 1977772
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Tertatolol--characteristics of the drug].
    Tomaszewski R, Kliz J.
    Wiad Lek; 1992 Mar; 45(5-6):196, 200, 204 passim. PubMed ID: 1360731
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Renal effects of intravenous tertatolol in essential arterial hypertension].
    Chaignon M, Brouard R, Lucsko M, Guédon J.
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1219-22. PubMed ID: 1979729
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Renal hemodynamic effects of tertatolol compared with those of propranolol in the conscious dog.
    Laubie M, Prost JF, Rochat C.
    Am J Nephrol; 1986 Jul; 6 Suppl 2():20-4. PubMed ID: 2879468
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of tertatolol in hypertensive patients with chronic renal failure.
    Beaufils M, Lantz B, Paillard F, Richet G.
    Am J Nephrol; 1986 Jul; 6 Suppl 2():50-4. PubMed ID: 2879474
    [Abstract] [Full Text] [Related]

  • 20. The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
    Verbeuren TJ, Zonnekeyn LL, Prost JF, Rochat C, Thomas JR, Herman AG.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):628-34. PubMed ID: 2900328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.